Skip to main content
. 2021 May 17;8(5):548–556. doi: 10.1093/ehjqcco/qcab037

Figure 1.

Figure 1

External validation for three sets of three clinical rule-based models: (A) Set 1: multi-morbid index ‘MMC1’ (C index 0.8451, 95% CI 0.8427–0.8476), CHADS2 (C index 0.7488, 95% CI 0.746–0.7516), CHA2DS2VASc (C index 0.7801, 95% CI 0.7772–0.7831); (B) Set 2: multi-morbid index/AF status (C index 0.8508, 95%CI 0.8483–0.8532), CHADS2/AF status (C index 0.7694, 95% CI 0.7667–0.7722), CHA2DS2VASc/AF status (C index 0.796, 95% CI 0.7931–0.7989); (C) Set 3: multi-morbid index/AF status/Medicare status (C index 0.8577, 95% CI 0.8553–0.86), CHADS2/AF status/Medicare status (C index 0.8343, 95% CI 0.8319–0.8368), CHA2DS2VASc/AF status/Medicare status (C index 0.8285, 95% CI 0.8259–0.8312).